...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: The problem...as I see it

This study was in heart failure patients, of course. So the results cannot be extrapolated to say that SGLT2 inhibtors will lower MACE in non-diabetics without heart failure. 

Share
New Message
Please login to post a reply